Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zbtb7b
|
ENSMUSG00000028042.9 | zinc finger and BTB domain containing 7B |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_89394381_89395222 | Zbtb7b | 25 | 0.864816 | -0.79 | 7.0e-13 | Click! |
chr3_89393362_89393859 | Zbtb7b | 25 | 0.890745 | -0.78 | 3.2e-12 | Click! |
chr3_89391710_89392572 | Zbtb7b | 72 | 0.616603 | -0.70 | 2.3e-09 | Click! |
chr3_89383749_89383951 | Zbtb7b | 3339 | 0.085829 | -0.37 | 5.6e-03 | Click! |
chr3_89387099_89387250 | Zbtb7b | 15 | 0.929880 | -0.36 | 7.0e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_81559146_81561402 | 14.54 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr16_44687184_44688343 | 13.68 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr3_87173881_87174644 | 12.50 |
Kirrel |
kirre like nephrin family adhesion molecule 1 |
288 |
0.89 |
chr7_31127074_31128340 | 11.94 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr8_70315603_70316677 | 11.69 |
Cers1 |
ceramide synthase 1 |
353 |
0.75 |
chr4_24430547_24430742 | 11.55 |
Gm27243 |
predicted gene 27243 |
246 |
0.94 |
chrY_90739614_90740540 | 11.54 |
Mid1-ps1 |
midline 1, pseudogene 1 |
12980 |
0.18 |
chr1_42693315_42693672 | 11.33 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
340 |
0.76 |
chr2_152050523_152051049 | 11.31 |
AA387200 |
expressed sequence AA387200 |
26022 |
0.12 |
chr6_36809275_36810322 | 11.04 |
Ptn |
pleiotrophin |
381 |
0.91 |
chr11_113188158_113188571 | 11.02 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
13458 |
0.24 |
chr4_22479124_22479682 | 11.00 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
8963 |
0.17 |
chr11_54304287_54304643 | 10.92 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
263 |
0.89 |
chr10_60115666_60116069 | 10.80 |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
9399 |
0.18 |
chr18_23037418_23037876 | 10.60 |
Nol4 |
nucleolar protein 4 |
1009 |
0.7 |
chr2_45225367_45225747 | 10.47 |
Gm28643 |
predicted gene 28643 |
68632 |
0.11 |
chr2_34107471_34107667 | 10.42 |
C230014O12Rik |
RIKEN cDNA C230014O12 gene |
160 |
0.96 |
chr3_88205532_88206477 | 10.40 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr3_127749245_127749655 | 10.34 |
Gm23279 |
predicted gene, 23279 |
17856 |
0.1 |
chr8_103314388_103314575 | 10.32 |
1600027J07Rik |
RIKEN cDNA 1600027J07 gene |
33053 |
0.2 |
chr17_13654565_13655321 | 10.22 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr13_83732174_83732508 | 10.19 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
225 |
0.89 |
chr11_6063825_6064308 | 10.10 |
Camk2b |
calcium/calmodulin-dependent protein kinase II, beta |
1472 |
0.4 |
chr2_121295300_121295921 | 10.09 |
Map1a |
microtubule-associated protein 1 A |
147 |
0.76 |
chr8_12915219_12915955 | 10.02 |
Gm15351 |
predicted gene 15351 |
32 |
0.8 |
chr14_75455687_75456060 | 10.00 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
109 |
0.97 |
chr9_107629988_107631141 | 9.72 |
Gm19721 |
predicted gene, 19721 |
1975 |
0.12 |
chr3_89320460_89321321 | 9.68 |
Efna3 |
ephrin A3 |
741 |
0.37 |
chr4_124881310_124881874 | 9.46 |
Epha10 |
Eph receptor A10 |
693 |
0.52 |
chr10_81229756_81230195 | 9.27 |
Atcay |
ataxia, cerebellar, Cayman type |
810 |
0.33 |
chr12_11455707_11456527 | 9.25 |
Rad51ap2 |
RAD51 associated protein 2 |
38 |
0.97 |
chr17_56475522_56476833 | 9.16 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
192 |
0.93 |
chr10_81472309_81472908 | 9.15 |
Celf5 |
CUGBP, Elav-like family member 5 |
394 |
0.64 |
chr2_166682899_166683229 | 9.10 |
Prex1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
20530 |
0.18 |
chr7_44310178_44311500 | 9.08 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chrX_99820087_99820510 | 9.03 |
Tmem28 |
transmembrane protein 28 |
723 |
0.74 |
chr4_22488420_22489023 | 9.03 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
355 |
0.83 |
chr13_36283759_36283936 | 9.03 |
Gm48766 |
predicted gene, 48766 |
31488 |
0.17 |
chr13_74639270_74640542 | 8.94 |
Erap1 |
endoplasmic reticulum aminopeptidase 1 |
33 |
0.97 |
chr12_58981232_58981506 | 8.92 |
Sec23a |
SEC23 homolog A, COPII coat complex component |
1335 |
0.35 |
chr8_69161565_69161757 | 8.80 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
20569 |
0.15 |
chr1_57218512_57218908 | 8.75 |
BC055402 |
cDNA sequence BC055402 |
3717 |
0.29 |
chr4_138325465_138326730 | 8.66 |
Gm27646 |
predicted gene, 27646 |
8 |
0.64 |
chr2_54435866_54436297 | 8.65 |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
236 |
0.96 |
chr3_56475903_56476451 | 8.49 |
Gm25727 |
predicted gene, 25727 |
30765 |
0.25 |
chr9_21197538_21198329 | 8.33 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
1228 |
0.29 |
chr17_23675766_23677157 | 8.32 |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
92 |
0.89 |
chr3_29541602_29541810 | 8.32 |
Egfem1 |
EGF-like and EMI domain containing 1 |
27800 |
0.23 |
chr5_27262113_27262387 | 8.17 |
Dpp6 |
dipeptidylpeptidase 6 |
275 |
0.94 |
chr4_44518914_44519072 | 8.14 |
Mir5120 |
microRNA 5120 |
88575 |
0.07 |
chr14_31933884_31934234 | 8.11 |
D830044D21Rik |
RIKEN cDNA D830044D21 gene |
27531 |
0.16 |
chr14_79724284_79724529 | 8.10 |
Mir759 |
microRNA 759 |
14025 |
0.13 |
chr14_12338554_12338736 | 8.01 |
Gm24578 |
predicted gene, 24578 |
4741 |
0.14 |
chr10_118102987_118104071 | 7.99 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
8988 |
0.17 |
chrX_48518492_48518694 | 7.96 |
Rab33a |
RAB33A, member RAS oncogene family |
692 |
0.65 |
chr11_6599159_6600158 | 7.96 |
Nacad |
NAC alpha domain containing |
266 |
0.81 |
chr16_17833131_17833677 | 7.94 |
B830017H08Rik |
RIKEN cDNA B830017H08 gene |
164 |
0.89 |
chr17_56551768_56552114 | 7.92 |
Gm20219 |
predicted gene, 20219 |
2446 |
0.18 |
chr10_51153468_51153678 | 7.92 |
Gm26257 |
predicted gene, 26257 |
28726 |
0.22 |
chr3_88239048_88239748 | 7.91 |
Gm3764 |
predicted gene 3764 |
10615 |
0.07 |
chr4_22491019_22491370 | 7.89 |
Gm30731 |
predicted gene, 30731 |
646 |
0.66 |
chr10_56892903_56893581 | 7.89 |
Gm48053 |
predicted gene, 48053 |
21523 |
0.23 |
chr4_33208877_33209633 | 7.88 |
Srsf12 |
serine and arginine-rich splicing factor 12 |
8 |
0.97 |
chr13_84752106_84752283 | 7.88 |
Gm26913 |
predicted gene, 26913 |
61253 |
0.15 |
chr9_124439906_124440949 | 7.84 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr2_56457671_56457868 | 7.83 |
Mir195b |
microRNA 195b |
328042 |
0.01 |
chr16_72610904_72611128 | 7.81 |
Robo1 |
roundabout guidance receptor 1 |
47316 |
0.2 |
chr6_113856666_113857208 | 7.81 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
34433 |
0.12 |
chr16_43503682_43504014 | 7.81 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
151 |
0.97 |
chr3_127408245_127408547 | 7.81 |
Ank2 |
ankyrin 2, brain |
558 |
0.7 |
chr9_65153293_65153715 | 7.80 |
Igdcc3 |
immunoglobulin superfamily, DCC subclass, member 3 |
12292 |
0.13 |
chr15_36967359_36968246 | 7.75 |
Gm34590 |
predicted gene, 34590 |
28938 |
0.13 |
chr13_19622971_19623817 | 7.73 |
Sfrp4 |
secreted frizzled-related protein 4 |
219 |
0.92 |
chr6_39903930_39904296 | 7.72 |
Tmem178b |
transmembrane protein 178B |
31042 |
0.14 |
chr1_42876896_42877054 | 7.70 |
Gm23126 |
predicted gene, 23126 |
10157 |
0.19 |
chr3_35405886_35406102 | 7.67 |
Gm43078 |
predicted gene 43078 |
7839 |
0.26 |
chr2_91399567_91399718 | 7.62 |
Gm22071 |
predicted gene, 22071 |
7494 |
0.17 |
chr6_10970567_10970901 | 7.57 |
AA545190 |
EST AA545190 |
3644 |
0.32 |
chr3_103575082_103575659 | 7.56 |
Syt6 |
synaptotagmin VI |
8 |
0.98 |
chr8_4492910_4494136 | 7.56 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr5_109556763_109557843 | 7.53 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr3_144411063_144411292 | 7.50 |
Gm5857 |
predicted gene 5857 |
16495 |
0.21 |
chr7_79531898_79532317 | 7.43 |
Gm35040 |
predicted gene, 35040 |
3936 |
0.11 |
chr16_37584654_37585373 | 7.42 |
Hgd |
homogentisate 1, 2-dioxygenase |
4731 |
0.16 |
chr1_81593953_81594167 | 7.42 |
Gm6198 |
predicted gene 6198 |
36577 |
0.2 |
chr18_36197046_36197216 | 7.41 |
Nrg2 |
neuregulin 2 |
101 |
0.97 |
chr2_150643808_150644024 | 7.34 |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
5801 |
0.14 |
chr12_49375905_49376245 | 7.32 |
Gm34304 |
predicted gene, 34304 |
5810 |
0.14 |
chr13_105250176_105250532 | 7.31 |
Rnf180 |
ring finger protein 180 |
20685 |
0.22 |
chr7_25006131_25006556 | 7.30 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
385 |
0.75 |
chr9_91365711_91366045 | 7.25 |
Zic1 |
zinc finger protein of the cerebellum 1 |
68 |
0.95 |
chr10_127531428_127531821 | 7.23 |
Nxph4 |
neurexophilin 4 |
2935 |
0.14 |
chr19_36553934_36555231 | 7.23 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr2_17514741_17514892 | 7.22 |
Nebl |
nebulette |
13508 |
0.23 |
chr3_5327075_5327408 | 7.18 |
Zfhx4 |
zinc finger homeodomain 4 |
85569 |
0.09 |
chr5_37028527_37029187 | 7.17 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
255 |
0.91 |
chrX_69666247_69666398 | 7.09 |
Gm8172 |
predicted pseudogene 8172 |
60077 |
0.15 |
chr4_6945076_6945264 | 7.05 |
Tox |
thymocyte selection-associated high mobility group box |
45313 |
0.19 |
chr6_119674280_119674487 | 7.04 |
Erc1 |
ELKS/RAB6-interacting/CAST family member 1 |
52278 |
0.15 |
chr11_101732407_101733143 | 7.03 |
Dhx8 |
DEAH (Asp-Glu-Ala-His) box polypeptide 8 |
144 |
0.94 |
chr3_88208529_88208713 | 7.02 |
Gm3764 |
predicted gene 3764 |
851 |
0.35 |
chr3_114031791_114032399 | 7.00 |
Col11a1 |
collagen, type XI, alpha 1 |
1461 |
0.58 |
chr13_84064676_84065083 | 6.98 |
Gm17750 |
predicted gene, 17750 |
107 |
0.97 |
chr7_73376050_73376284 | 6.96 |
A730056A06Rik |
RIKEN cDNA A730056A06 gene |
393 |
0.61 |
chr2_152068961_152069179 | 6.94 |
AA387200 |
expressed sequence AA387200 |
7738 |
0.14 |
chr13_105256983_105257274 | 6.94 |
Rnf180 |
ring finger protein 180 |
13911 |
0.24 |
chr6_134888153_134888812 | 6.93 |
Gpr19 |
G protein-coupled receptor 19 |
650 |
0.56 |
chr2_124524230_124524449 | 6.91 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
85767 |
0.1 |
chr17_45549636_45549918 | 6.89 |
Tmem151b |
transmembrane protein 151B |
100 |
0.93 |
chr2_106425459_106425618 | 6.88 |
Dcdc5 |
doublecortin domain containing 5 |
41851 |
0.18 |
chr18_79049027_79050094 | 6.87 |
Setbp1 |
SET binding protein 1 |
59831 |
0.15 |
chr4_141010513_141010896 | 6.86 |
Mfap2 |
microfibrillar-associated protein 2 |
60 |
0.95 |
chr1_132200708_132201234 | 6.83 |
Lemd1 |
LEM domain containing 1 |
8 |
0.96 |
chr10_83722468_83723424 | 6.83 |
1500009L16Rik |
RIKEN cDNA 1500009L16 gene |
20 |
0.98 |
chr3_37419062_37420017 | 6.81 |
Nudt6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
18 |
0.84 |
chr10_46827266_46827417 | 6.81 |
Gm25650 |
predicted gene, 25650 |
11166 |
0.24 |
chr6_107534577_107534757 | 6.81 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
4899 |
0.26 |
chr11_34112866_34113040 | 6.78 |
4930469K13Rik |
RIKEN cDNA 4930469K13 gene |
14399 |
0.18 |
chr4_76450072_76450345 | 6.72 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
228 |
0.89 |
chr8_69160726_69160877 | 6.72 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
19848 |
0.15 |
chr8_12105221_12105384 | 6.72 |
B020031H02Rik |
RIKEN cDNA B020031H02 gene |
156963 |
0.03 |
chr7_25152470_25152621 | 6.71 |
D930028M14Rik |
RIKEN cDNA D930028M14 gene |
88 |
0.95 |
chr18_25678184_25678915 | 6.71 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
35221 |
0.19 |
chr12_4523765_4524306 | 6.71 |
Gm31938 |
predicted gene, 31938 |
78 |
0.96 |
chr11_117497679_117497848 | 6.71 |
Gm11733 |
predicted gene 11733 |
13395 |
0.14 |
chr7_79525373_79525570 | 6.70 |
Mir9-3hg |
Mir9-3 host gene |
2379 |
0.14 |
chr7_4547209_4547689 | 6.68 |
Syt5 |
synaptotagmin V |
92 |
0.92 |
chr10_16053290_16053544 | 6.68 |
C330004P14Rik |
RIKEN cDNA C330004P14 gene |
261640 |
0.02 |
chr14_76254562_76255004 | 6.64 |
2900040C04Rik |
RIKEN cDNA 2900040C04 gene |
3326 |
0.28 |
chr2_105659788_105659939 | 6.61 |
Paupar |
Pax6 upstream antisense RNA |
1480 |
0.36 |
chr10_127078401_127078887 | 6.60 |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
263 |
0.78 |
chr15_32172538_32172721 | 6.60 |
Tas2r119 |
taste receptor, type 2, member 119 |
4660 |
0.24 |
chr11_26103813_26103985 | 6.58 |
5730522E02Rik |
RIKEN cDNA 5730522E02 gene |
22299 |
0.26 |
chr11_112817897_112818851 | 6.58 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
6780 |
0.2 |
chr13_42709847_42710338 | 6.57 |
Phactr1 |
phosphatase and actin regulator 1 |
511 |
0.85 |
chr1_25229054_25229261 | 6.56 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
57 |
0.97 |
chr8_48204156_48204432 | 6.55 |
Gm32842 |
predicted gene, 32842 |
66691 |
0.11 |
chr2_174109835_174111101 | 6.55 |
Npepl1 |
aminopeptidase-like 1 |
119 |
0.96 |
chr3_108085301_108086522 | 6.55 |
Gm12500 |
predicted gene 12500 |
65 |
0.8 |
chr2_13575918_13576451 | 6.54 |
Vim |
vimentin |
1661 |
0.43 |
chr1_25892841_25892992 | 6.53 |
Gm9884 |
predicted gene 9884 |
62259 |
0.08 |
chr8_4212633_4214018 | 6.52 |
Prr36 |
proline rich 36 |
3587 |
0.11 |
chr6_36776057_36776246 | 6.51 |
Ptn |
pleiotrophin |
34028 |
0.2 |
chr5_137734700_137735086 | 6.50 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
4825 |
0.1 |
chr12_27064915_27065316 | 6.50 |
Gm9866 |
predicted gene 9866 |
49880 |
0.18 |
chr6_113194723_113194960 | 6.48 |
Lhfpl4 |
lipoma HMGIC fusion partner-like protein 4 |
543 |
0.71 |
chr2_93228462_93228874 | 6.48 |
Tspan18 |
tetraspanin 18 |
882 |
0.65 |
chr6_134887759_134888112 | 6.45 |
Gpr19 |
G protein-coupled receptor 19 |
103 |
0.94 |
chr12_70346175_70346671 | 6.44 |
Trim9 |
tripartite motif-containing 9 |
666 |
0.55 |
chr12_111694014_111694759 | 6.40 |
Gm36635 |
predicted gene, 36635 |
8696 |
0.09 |
chr16_39302875_39303086 | 6.40 |
Gm36742 |
predicted gene, 36742 |
114074 |
0.06 |
chr12_54034761_54035094 | 6.38 |
1700060O08Rik |
RIKEN cDNA 1700060O08 gene |
44465 |
0.17 |
chr10_79681206_79682337 | 6.37 |
Cdc34 |
cell division cycle 34 |
424 |
0.63 |
chr12_44401957_44402486 | 6.35 |
Gm48182 |
predicted gene, 48182 |
7569 |
0.2 |
chr9_41918970_41919408 | 6.35 |
Gm40513 |
predicted gene, 40513 |
28585 |
0.14 |
chr3_34650209_34650435 | 6.34 |
Sox2 |
SRY (sex determining region Y)-box 2 |
83 |
0.95 |
chr1_44101573_44102245 | 6.32 |
Tex30 |
testis expressed 30 |
104 |
0.94 |
chr8_9771269_9772260 | 6.32 |
Fam155a |
family with sequence similarity 155, member A |
603 |
0.53 |
chr14_54912170_54912471 | 6.29 |
Slc22a17 |
solute carrier family 22 (organic cation transporter), member 17 |
194 |
0.83 |
chr14_54924638_54925613 | 6.27 |
Efs |
embryonal Fyn-associated substrate |
530 |
0.49 |
chr14_35112651_35112809 | 6.27 |
Gm49034 |
predicted gene, 49034 |
106708 |
0.07 |
chr14_76032657_76033188 | 6.22 |
Gtf2f2 |
general transcription factor IIF, polypeptide 2 |
22057 |
0.18 |
chr14_46661801_46661963 | 6.22 |
Gm48917 |
predicted gene, 48917 |
9820 |
0.12 |
chr8_12320127_12320481 | 6.20 |
Gm33175 |
predicted gene, 33175 |
824 |
0.59 |
chr12_26936808_26937007 | 6.19 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
102034 |
0.08 |
chr2_55435367_55435518 | 6.18 |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
528 |
0.84 |
chr2_179786993_179787232 | 6.17 |
Cdh4 |
cadherin 4 |
9949 |
0.27 |
chr6_126645719_126645911 | 6.16 |
Kcna1 |
potassium voltage-gated channel, shaker-related subfamily, member 1 |
569 |
0.78 |
chr3_19406344_19406802 | 6.16 |
Pde7a |
phosphodiesterase 7A |
95251 |
0.07 |
chr9_16440789_16440940 | 6.15 |
Gm48726 |
predicted gene, 48726 |
5469 |
0.32 |
chr7_19094759_19096427 | 6.13 |
Six5 |
sine oculis-related homeobox 5 |
999 |
0.28 |
chr3_131085281_131085432 | 6.13 |
Lef1 |
lymphoid enhancer binding factor 1 |
25115 |
0.14 |
chr8_3493298_3493991 | 6.10 |
Zfp358 |
zinc finger protein 358 |
474 |
0.67 |
chr17_3275020_3275269 | 6.09 |
Gm34035 |
predicted gene, 34035 |
8063 |
0.17 |
chr10_96955859_96956119 | 6.09 |
Gm33981 |
predicted gene, 33981 |
2882 |
0.33 |
chrX_99819373_99819820 | 6.07 |
Tmem28 |
transmembrane protein 28 |
1425 |
0.49 |
chr18_45016336_45016496 | 6.06 |
Gm31706 |
predicted gene, 31706 |
28446 |
0.16 |
chr2_181134359_181134617 | 6.05 |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
434 |
0.75 |
chr4_85256505_85256861 | 6.04 |
Gm12413 |
predicted gene 12413 |
10921 |
0.25 |
chr2_154421078_154421682 | 6.03 |
Snta1 |
syntrophin, acidic 1 |
13281 |
0.16 |
chr2_151972879_151973593 | 6.02 |
Fam110a |
family with sequence similarity 110, member A |
158 |
0.93 |
chr4_124035672_124036030 | 6.00 |
Gm12902 |
predicted gene 12902 |
109617 |
0.05 |
chr10_85023052_85023242 | 5.97 |
Ric8b |
RIC8 guanine nucleotide exchange factor B |
14431 |
0.22 |
chr11_107793325_107793499 | 5.96 |
Gm11650 |
predicted gene 11650 |
454 |
0.72 |
chr13_28792210_28792378 | 5.95 |
Gm17528 |
predicted gene, 17528 |
34829 |
0.16 |
chr9_102249239_102249432 | 5.95 |
Gm37260 |
predicted gene, 37260 |
24401 |
0.17 |
chr5_149537914_149538065 | 5.94 |
Gm15997 |
predicted gene 15997 |
41 |
0.96 |
chr2_17670178_17670376 | 5.94 |
Nebl |
nebulette |
60766 |
0.13 |
chr10_23349524_23350360 | 5.91 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
39 |
0.99 |
chr1_34665546_34665842 | 5.90 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
12494 |
0.12 |
chr4_91371091_91372260 | 5.90 |
Elavl2 |
ELAV like RNA binding protein 1 |
281 |
0.88 |
chr9_98032555_98033050 | 5.89 |
Clstn2 |
calsyntenin 2 |
181 |
0.96 |
chr18_72725028_72725395 | 5.89 |
Gm31819 |
predicted gene, 31819 |
144 |
0.98 |
chr17_73540895_73541046 | 5.89 |
Galnt14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
1075 |
0.5 |
chr11_42000451_42000692 | 5.88 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
39 |
0.99 |
chr2_32875948_32876955 | 5.86 |
Fam129b |
family with sequence similarity 129, member B |
337 |
0.54 |
chr19_28394841_28395181 | 5.86 |
Glis3 |
GLIS family zinc finger 3 |
69005 |
0.13 |
chr7_79505823_79506244 | 5.85 |
Mir9-3 |
microRNA 9-3 |
769 |
0.43 |
chr7_78579219_78579393 | 5.84 |
Gm9885 |
predicted gene 9885 |
476 |
0.54 |
chr18_60923916_60924296 | 5.84 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
1512 |
0.31 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 16.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
3.6 | 18.2 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
3.5 | 14.2 | GO:0061743 | motor learning(GO:0061743) |
3.5 | 10.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
3.4 | 13.6 | GO:0007412 | axon target recognition(GO:0007412) |
3.2 | 3.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
3.0 | 12.0 | GO:0090427 | activation of meiosis(GO:0090427) |
2.9 | 17.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
2.9 | 11.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
2.9 | 5.8 | GO:0086068 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
2.9 | 23.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.9 | 8.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
2.9 | 11.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.8 | 11.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.8 | 16.5 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.7 | 11.0 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
2.7 | 10.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
2.6 | 7.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.6 | 7.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
2.6 | 2.6 | GO:0021586 | pons maturation(GO:0021586) |
2.5 | 20.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.5 | 5.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
2.4 | 7.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
2.3 | 4.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.3 | 6.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.2 | 8.8 | GO:0071625 | vocalization behavior(GO:0071625) |
2.2 | 6.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.2 | 8.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.1 | 8.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.1 | 8.2 | GO:0046959 | habituation(GO:0046959) |
2.1 | 6.2 | GO:0048880 | sensory system development(GO:0048880) |
2.0 | 12.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.0 | 6.1 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
2.0 | 8.0 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.0 | 8.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.9 | 5.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.9 | 3.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.8 | 3.7 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.8 | 3.7 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.8 | 3.6 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.8 | 5.3 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.7 | 7.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
1.7 | 10.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.7 | 5.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.7 | 8.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.7 | 13.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.7 | 8.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.7 | 5.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.7 | 5.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.7 | 6.6 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.6 | 3.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.6 | 1.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.6 | 1.6 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.6 | 9.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.6 | 6.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.6 | 4.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.6 | 1.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.6 | 6.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.6 | 4.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.6 | 4.7 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
1.5 | 20.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.5 | 9.2 | GO:0035989 | tendon development(GO:0035989) |
1.5 | 1.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.5 | 10.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.5 | 3.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.5 | 7.4 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
1.5 | 4.4 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
1.5 | 5.8 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.4 | 5.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.4 | 14.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.4 | 4.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.4 | 4.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.4 | 1.4 | GO:0060166 | olfactory pit development(GO:0060166) |
1.4 | 8.2 | GO:0003139 | secondary heart field specification(GO:0003139) |
1.4 | 8.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.3 | 12.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
1.3 | 3.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.3 | 7.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.3 | 1.3 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
1.3 | 3.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.3 | 1.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.3 | 3.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.3 | 13.8 | GO:0022038 | corpus callosum development(GO:0022038) |
1.3 | 2.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.2 | 5.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
1.2 | 9.8 | GO:0060013 | righting reflex(GO:0060013) |
1.2 | 3.6 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.2 | 2.4 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
1.2 | 3.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.2 | 3.6 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.2 | 2.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.2 | 2.4 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.2 | 1.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.2 | 4.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.2 | 3.6 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
1.2 | 9.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.2 | 3.6 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.2 | 3.5 | GO:0030070 | insulin processing(GO:0030070) |
1.2 | 3.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.2 | 2.3 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.2 | 2.3 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
1.1 | 1.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.1 | 4.5 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.1 | 5.6 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.1 | 2.2 | GO:0030421 | defecation(GO:0030421) |
1.1 | 7.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
1.1 | 12.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.1 | 4.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.1 | 3.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.1 | 4.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.1 | 3.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.1 | 2.1 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.1 | 11.7 | GO:0060004 | reflex(GO:0060004) |
1.1 | 2.1 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.1 | 4.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.1 | 4.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.0 | 6.3 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.0 | 3.1 | GO:0006868 | glutamine transport(GO:0006868) |
1.0 | 3.1 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
1.0 | 4.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.0 | 4.1 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.0 | 2.0 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.0 | 2.0 | GO:1902001 | plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
1.0 | 3.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.0 | 3.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.0 | 8.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.0 | 4.8 | GO:0030432 | peristalsis(GO:0030432) |
0.9 | 2.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.9 | 3.7 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.9 | 1.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.9 | 4.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.9 | 5.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.9 | 2.8 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.9 | 3.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.9 | 8.3 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.9 | 1.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.9 | 2.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.9 | 4.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.9 | 2.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.9 | 0.9 | GO:0090135 | actin filament branching(GO:0090135) |
0.9 | 3.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.9 | 1.8 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.9 | 0.9 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.9 | 4.4 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.9 | 1.8 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.9 | 3.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.9 | 4.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.9 | 1.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.8 | 3.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.8 | 1.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.8 | 2.5 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.8 | 2.5 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.8 | 1.7 | GO:0046958 | nonassociative learning(GO:0046958) |
0.8 | 2.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.8 | 6.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.8 | 2.4 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.8 | 8.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.8 | 0.8 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.8 | 48.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.8 | 2.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.8 | 3.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.8 | 4.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.8 | 2.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.8 | 3.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.8 | 5.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.8 | 2.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 5.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.8 | 2.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.8 | 1.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 12.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.8 | 7.6 | GO:0008038 | neuron recognition(GO:0008038) |
0.8 | 2.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.7 | 1.5 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.7 | 2.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.7 | 2.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.7 | 2.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.7 | 3.7 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.7 | 2.9 | GO:0060437 | lung growth(GO:0060437) |
0.7 | 2.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.7 | 1.5 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.7 | 2.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 2.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.7 | 0.7 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.7 | 3.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.7 | 2.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 2.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.7 | 1.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.7 | 4.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.7 | 8.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.7 | 1.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.7 | 1.4 | GO:0008355 | olfactory learning(GO:0008355) |
0.7 | 1.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.7 | 1.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.7 | 1.4 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.7 | 2.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 2.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.7 | 0.7 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.7 | 6.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.7 | 2.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 0.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.7 | 20.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.7 | 2.0 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 3.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.7 | 1.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.7 | 1.3 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.7 | 17.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.7 | 3.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.6 | 2.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.6 | 2.6 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.6 | 1.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 1.9 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.6 | 1.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.6 | 0.6 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.6 | 3.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.6 | 3.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.6 | 0.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.6 | 2.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.6 | 2.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.6 | 1.3 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.6 | 1.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.6 | 3.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.6 | 1.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 4.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.6 | 1.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.6 | 3.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.6 | 0.6 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.6 | 0.6 | GO:0099612 | protein localization to axon(GO:0099612) |
0.6 | 3.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.6 | 11.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.6 | 5.4 | GO:0015816 | glycine transport(GO:0015816) |
0.6 | 2.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.6 | 0.6 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.6 | 1.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.6 | 1.8 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.6 | 2.3 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.6 | 1.7 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.6 | 9.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.6 | 1.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.6 | 0.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 7.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.6 | 1.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.6 | 2.8 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.6 | 1.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.6 | 3.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.6 | 6.7 | GO:0001964 | startle response(GO:0001964) |
0.6 | 4.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.6 | 2.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 33.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 3.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.5 | 0.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.5 | 1.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.5 | 4.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.5 | 4.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.5 | 6.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.5 | 2.1 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 2.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.5 | 1.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.5 | 0.5 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.5 | 1.6 | GO:0014028 | notochord formation(GO:0014028) |
0.5 | 1.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.5 | 2.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.5 | 1.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.5 | 0.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.5 | 6.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.5 | 1.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 1.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.5 | 7.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.5 | 3.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.5 | 1.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.5 | 2.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.5 | 2.5 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.5 | 2.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 1.0 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.5 | 1.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.5 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 7.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 1.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.5 | 2.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.5 | 0.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.5 | 1.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.5 | 1.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.5 | 9.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.5 | 4.7 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.5 | 1.4 | GO:2001053 | regulation of mesenchymal cell apoptotic process(GO:2001053) |
0.5 | 1.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.5 | 0.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.5 | 1.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 0.5 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.5 | 0.9 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.5 | 0.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.5 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 5.9 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.5 | 1.4 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 3.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 0.9 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.4 | 0.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.4 | 3.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 0.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.4 | 0.9 | GO:2000064 | regulation of cortisol biosynthetic process(GO:2000064) |
0.4 | 0.4 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.4 | 0.9 | GO:0061055 | myotome development(GO:0061055) |
0.4 | 0.9 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.4 | 1.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 1.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.4 | 2.6 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 1.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.4 | 0.4 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.4 | 1.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 0.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 3.8 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.4 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 0.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 0.4 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.4 | 1.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.4 | 1.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.4 | 1.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 1.2 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 0.8 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.4 | 1.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 2.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 1.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.4 | 1.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.4 | 1.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 1.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 1.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.4 | 1.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.4 | 1.2 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 0.4 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.4 | 0.8 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.4 | 3.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.4 | 0.8 | GO:2000729 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.4 | 1.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 0.4 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.4 | 4.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 0.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 2.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 1.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.4 | 1.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.3 | 0.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.3 | 1.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 1.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 1.0 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 2.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 0.7 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 0.3 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.3 | 2.7 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.3 | 3.4 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.3 | 0.7 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.0 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 1.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.3 | 1.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 0.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 0.7 | GO:0010042 | response to manganese ion(GO:0010042) |
0.3 | 2.3 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.3 | 0.3 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.3 | 0.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 1.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 0.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 1.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 1.0 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 2.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 0.3 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.3 | 1.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 1.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 0.6 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.3 | 1.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.3 | 3.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.3 | 1.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 1.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 1.6 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 1.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.3 | 0.3 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 2.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 0.3 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.3 | 1.5 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.3 | 0.6 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.3 | 2.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 0.3 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.3 | 0.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.9 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 0.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 19.1 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.3 | 0.3 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.3 | 4.0 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.3 | 1.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 1.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 2.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 1.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 3.9 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.3 | 1.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 0.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 0.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 1.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.3 | 2.1 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 2.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.3 | 1.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.3 | 0.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.3 | 0.8 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.3 | 0.3 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.3 | 2.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.3 | 1.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 0.3 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 0.8 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.3 | 1.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 3.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.3 | 1.5 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.3 | 3.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 1.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 1.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.2 | 1.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 0.7 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.2 | 1.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 1.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 2.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 7.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.2 | 1.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 2.9 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 0.5 | GO:0009750 | response to fructose(GO:0009750) |
0.2 | 0.7 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 1.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.2 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.2 | 6.9 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.2 | 0.2 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 0.5 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.2 | 0.2 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.2 | 0.2 | GO:0032347 | regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.2 | 0.2 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.2 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 4.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.2 | 1.1 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.2 | 2.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 0.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 5.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.2 | 0.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.4 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 1.3 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.2 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.8 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.2 | 0.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.4 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.2 | 1.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.4 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.2 | 1.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.2 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 0.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 1.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.4 | GO:0051938 | L-glutamate import(GO:0051938) |
0.2 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.2 | 1.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 2.0 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.2 | 0.4 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.2 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 1.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 0.4 | GO:0015824 | proline transport(GO:0015824) |
0.2 | 0.8 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.6 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 3.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 0.6 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.2 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.2 | 0.7 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 2.0 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.2 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.2 | 0.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 1.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.9 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 0.7 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.2 | 0.7 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.2 | 1.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 2.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 2.0 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 0.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.2 | GO:0060459 | left lung development(GO:0060459) |
0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.8 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.2 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.2 | 0.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.2 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.2 | 2.4 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 1.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.5 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 0.5 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 0.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.2 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.2 | 0.5 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.6 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.7 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 1.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 3.4 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.4 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 1.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.5 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.4 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.8 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.3 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.8 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.8 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.1 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.8 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.9 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 8.9 | GO:0007626 | locomotory behavior(GO:0007626) |
0.1 | 0.4 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 1.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.4 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 1.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.5 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.5 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.6 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.1 | 1.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 1.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.2 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.3 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 2.1 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.8 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.3 | GO:0072044 | collecting duct development(GO:0072044) |
0.1 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.2 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.1 | 3.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.8 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.8 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 1.0 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.2 | GO:0090192 | regulation of glomerulus development(GO:0090192) |
0.1 | 0.2 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.1 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.4 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.3 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.7 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.4 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.9 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.1 | 0.3 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.6 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.7 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.1 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.5 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 1.5 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.1 | 0.1 | GO:0086011 | membrane repolarization during action potential(GO:0086011) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.3 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.3 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 0.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 1.2 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.3 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.1 | 1.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.4 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 0.7 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.7 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 2.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.5 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.5 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.4 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.7 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.7 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.0 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.4 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.4 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.8 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.0 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.0 | 0.1 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 0.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.0 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.0 | 0.0 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.0 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.0 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.0 | 0.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.0 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.6 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.0 | GO:0045357 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.0 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.0 | 0.0 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.0 | 0.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 26.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.4 | 14.5 | GO:0043083 | synaptic cleft(GO:0043083) |
2.2 | 4.4 | GO:0097441 | basilar dendrite(GO:0097441) |
2.1 | 6.4 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.1 | 2.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.0 | 10.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.8 | 5.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.8 | 21.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.8 | 9.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.8 | 53.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.7 | 5.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.6 | 6.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.6 | 4.7 | GO:0072534 | perineuronal net(GO:0072534) |
1.5 | 26.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.4 | 7.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.4 | 1.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.3 | 2.7 | GO:0097433 | dense body(GO:0097433) |
1.3 | 17.4 | GO:0033268 | node of Ranvier(GO:0033268) |
1.2 | 3.5 | GO:0044308 | axonal spine(GO:0044308) |
1.1 | 4.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.1 | 3.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.1 | 9.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.0 | 5.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.0 | 5.1 | GO:0070695 | FHF complex(GO:0070695) |
1.0 | 8.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.0 | 40.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.0 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.0 | 23.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.9 | 2.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.9 | 5.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.9 | 2.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.9 | 3.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.9 | 2.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 4.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 4.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.8 | 3.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.8 | 10.1 | GO:0031045 | dense core granule(GO:0031045) |
0.8 | 4.6 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 3.0 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 2.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 0.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.7 | 5.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.7 | 2.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 17.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 2.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.7 | 7.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.6 | 7.1 | GO:0001527 | microfibril(GO:0001527) |
0.6 | 4.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 7.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 1.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.6 | 7.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.6 | 1.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.6 | 5.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 2.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 2.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 6.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.5 | 1.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 1.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 2.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 25.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 6.2 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.5 | 1.0 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 6.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 67.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.5 | 1.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 15.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.5 | 1.9 | GO:0043205 | fibril(GO:0043205) |
0.5 | 9.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 2.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 2.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 1.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 2.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 1.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 4.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 1.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 5.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.4 | 1.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 1.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 5.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 2.3 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 35.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 4.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.4 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.4 | 1.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 1.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 1.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 3.6 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 1.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 1.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 0.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 0.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 0.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 20.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.3 | 2.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 1.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 2.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 2.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 2.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 1.8 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 15.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 34.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 2.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 0.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.2 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.2 | 2.3 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 3.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 3.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 2.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 1.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 0.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 2.6 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 0.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 0.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 5.1 | GO:0044309 | neuron spine(GO:0044309) |
0.2 | 2.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 1.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.8 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.5 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.8 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 17.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 3.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.2 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.3 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 2.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.0 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.0 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
3.3 | 9.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
3.0 | 21.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
3.0 | 9.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
2.8 | 11.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
2.6 | 13.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.3 | 11.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.1 | 8.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.1 | 8.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.0 | 6.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.0 | 6.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.0 | 10.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.9 | 5.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.9 | 7.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.9 | 9.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.7 | 5.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.6 | 11.4 | GO:0003680 | AT DNA binding(GO:0003680) |
1.6 | 4.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.5 | 11.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.5 | 4.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.4 | 5.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.4 | 8.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.3 | 5.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.3 | 4.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.3 | 4.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.3 | 10.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.3 | 21.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.3 | 8.8 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.2 | 40.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.2 | 8.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.2 | 3.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.2 | 5.9 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
1.2 | 3.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.2 | 8.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.1 | 5.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.1 | 4.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.1 | 5.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.1 | 16.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.1 | 4.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.1 | 8.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.0 | 3.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.0 | 3.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.0 | 2.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.0 | 7.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.9 | 7.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.9 | 2.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.9 | 8.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.9 | 0.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.9 | 4.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.9 | 2.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.9 | 7.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.8 | 0.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.8 | 2.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.8 | 16.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 3.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.8 | 3.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.8 | 3.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.8 | 3.1 | GO:0038100 | nodal binding(GO:0038100) |
0.8 | 5.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.8 | 3.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.8 | 2.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.8 | 2.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.8 | 3.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.7 | 3.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.7 | 3.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.7 | 3.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 2.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.7 | 5.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.7 | 2.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.7 | 1.4 | GO:0070905 | serine binding(GO:0070905) |
0.7 | 2.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 4.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.7 | 5.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.7 | 2.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.7 | 18.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.6 | 2.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.6 | 1.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.6 | 6.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.6 | 1.9 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 7.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.6 | 1.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.6 | 1.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.6 | 2.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.6 | 4.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.6 | 8.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.6 | 1.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.6 | 1.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 1.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 6.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.6 | 1.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.6 | 1.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.6 | 7.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.6 | 10.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.5 | 1.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.5 | 6.0 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 8.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 22.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.5 | 2.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 12.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 2.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.5 | 1.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 2.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.5 | 5.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.5 | 3.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.5 | 2.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 4.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.5 | 2.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.5 | 1.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 1.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 2.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.5 | 4.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 1.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 3.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 3.9 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 5.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.5 | 2.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.5 | 1.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 1.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 14.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 2.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 1.4 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 0.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.4 | 2.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.4 | 3.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 5.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 1.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 0.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.4 | 0.8 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 1.3 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.4 | 2.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 1.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 1.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 1.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 9.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 3.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 0.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 5.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 1.2 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.4 | 6.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 0.8 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.4 | 3.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 1.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 3.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 1.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 4.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 1.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 8.4 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 1.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 1.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 1.1 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 1.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.4 | 1.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 2.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 4.7 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 1.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 1.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 11.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 1.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 2.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 1.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 15.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 3.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 1.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 3.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 0.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 6.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 2.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.3 | 0.3 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.3 | 2.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 3.7 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 0.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 5.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 0.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 26.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.3 | 1.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 3.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 1.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 7.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 1.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 2.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 1.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 1.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 0.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 1.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 1.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 7.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 1.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 1.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 2.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 1.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.0 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 2.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 8.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 1.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.2 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 1.0 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 2.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 3.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 4.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 3.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 2.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 3.9 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 2.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 2.6 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.9 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.2 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 2.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 1.8 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.2 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.2 | 2.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 0.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 1.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 0.8 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 1.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 1.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 4.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 0.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 0.2 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 2.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.1 | GO:0034857 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 7.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 1.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.6 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 2.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 1.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 1.0 | GO:0034894 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.5 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 1.2 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 1.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 1.9 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 2.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 2.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 3.1 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 3.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 2.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 2.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 3.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 4.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 3.8 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 3.3 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.3 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 3.1 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.9 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 1.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.9 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 21.1 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.6 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.0 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 1.3 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 31.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.5 | 3.0 | PID REELIN PATHWAY | Reelin signaling pathway |
1.0 | 29.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.7 | 6.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.7 | 3.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.6 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.6 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.5 | 13.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 7.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.4 | 5.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 1.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 3.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 3.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 8.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 5.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 7.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 4.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 1.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 0.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 43.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 5.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 1.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 2.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 3.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 4.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 3.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.9 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 1.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 6.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 1.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 27.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.4 | 21.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.2 | 53.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.2 | 17.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.1 | 4.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.1 | 11.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.1 | 2.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
1.0 | 7.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.9 | 6.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.9 | 11.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.8 | 0.8 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.8 | 2.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.7 | 9.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.7 | 9.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 8.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 11.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.7 | 8.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.7 | 10.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.7 | 7.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.7 | 15.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 8.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 6.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 4.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 12.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 1.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.5 | 7.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 9.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 1.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.5 | 6.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.5 | 2.9 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.5 | 5.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 16.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 1.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 1.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 3.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 4.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 0.7 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.4 | 0.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 0.7 | REACTOME IMMUNE SYSTEM | Genes involved in Immune System |
0.3 | 0.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 3.8 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.3 | 2.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 0.3 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.3 | 2.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 0.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 3.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 4.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 1.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 0.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 0.2 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.2 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 0.8 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 3.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 2.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 1.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 2.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 3.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 0.9 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 0.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 1.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 2.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 1.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 3.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 5.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.7 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 3.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 3.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 5.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.1 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.1 | 3.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 8.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.8 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 1.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 0.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |